CTOs on the Move


 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

eCare21

eCare21`s mHealth application collects, compares and analyzes real-time information about users health and wellness. eCare21 integrates the efforts of families, doctors, nurses, volunteers, businesses – and seniors themselves to build a care model suitable for the 21st century. eCare21 seamlessly integrates with wearable and medical devices, Electronic Health Records and healthcare management systems, providing a single point continuous care solution for seniors.

Sagamore Health Network

Sagamore Health Network, Inc. is a Carmel, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SoftScript

SoftScript is a Santa Monica, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Theorem Clinical Research

Theorem Clinical Research is a King Of Prussia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Icario Health

Icario is a health action company that frees you to help people live healthier lives by helping you connect with them like they`re human. With over 100 million+ member connections, Icario is a health action platform that unites pioneering technology, data science, and behavioral insights to connect everyone to better health. Our mission is to make the world a healthier place, one person at a time. In 2020, Revel + NovuHealth joined forces to create Icario because we knew we could do better together—creating value by uniting pioneering technology, data science, and behavioral insights to make the world a healthier place, one person at a time. There is an island in the Aegean Sea where people live extremely long lives. They`re happy, too. Families are close. They eat well. They exercise. And they stay connected with each other, and not just by smartphone. This got us thinking. What if we apply what we learn from the Blue Zone island of Ikaria (our namesake), add pioneering technology and exabytes of data, and help healthcare connect better with everyone? We`ll have a lot more healthy, happy people, and that`s a pretty good thing. As an organization, we`re a collaborative team of pioneers, inventors, and systems thinkers. We speak truth, are driven by data, and sweat the details. We`re a friendly and easygoing group, but we work hard because we are mission-driven, we know a better way, and we`re here to make it happen.